Key Facts

Lilly at a Glance

• Founded May 10, 1876

• Headquarters located in Indianapolis, Indiana, U.S.A

• Lilly introduced the world's first commercial insulin in 1923

• More than 46,000 employees worldwide

• More than 10,000 employees engaged in research and development

• Products marketed in approximately 105 countries

Research & Development

• R&D expenditure (2023) $9.3 billion  

• R&D as a percentage of sales: 27.3% 

• Percentage of total workforce engaged in R&D: 23.7% 

• R&D facilities located in 7 countries 

• Clinical research conducted in more than 55 countries 

• Manufacturing plants located in 9 countries, including the US, Ireland, Italy, France and Spain.

Our Employees

as of September 2024

• 46,240 employees worldwide 

• 21,465 employees in the US

• 24,775 employees outside US

• 3,615 employees in Ireland (31 ^st March 2024)

• Percentage of Lilly Ireland leadership positions occupied by women: 55% (31 ^st March 2024)

Social Impact

• Lilly employees, retirees and the Lilly Foundation contributed more than $12 million to United Way in 2022
  

• Since 2009, Lilly has donated more than 5.2 million vials and cartridges of insulin through  Life for a Child

• 200,000 people screened for breast and cervical cancer in Kenya through AMPATH partnership

• More than 1 million employee volunteer hours through Lilly Global Day of Service since 2008

Cost of Pharmaceuticals

• Average cost to discover and develop a new drug: $2.6 billion

• Average length of time from discovery to patient: 10 years